首页> 外文期刊>Scientific reports. >Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease
【24h】

Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease

机译:EV-A71相关手足口病的神经系统并发症和心肺功能衰竭的危险因素

获取原文
           

摘要

From 2010 to 2012, large outbreaks of EV-A71-related- hand foot and mouth disease (HFMD) occurred annually in China. Some cases had neurological complications and were closely associated with fatal cardiopulmonary collapse, but not all children with central nervous system (CNS) involvement demonstrated a poor prognosis. To identify which patients and which neurological complications are more likely to progress to cardiopulmonary failure, we retrospectively studied 1,125 paediatric inpatients diagnosed with EV-A71-related HFMD in Hunan province, including 1,017 cases with CNS involvement. These patients were divided into cardiopulmonary failure (976 people) group and group without cardiopulmonary failure (149 people). A logistic regression analysis was used to compare the clinical symptoms, laboratory test results, and neurological complications between these two groups. The most significant risk factors included young age, fever duration ≥3 days, coma, limb weakness, drowsiness and ANS involvement. Patients with brainstem encephalitis and more CNS-involved regions were more likely to progress to cardiopulmonary failure. These findings can help front-line clinicians rapidly and accurately determine patient prognosis, thus rationally distributing the limited medical resources and implementing interventions as early as possible.
机译:从2010年到2012年,中国每年爆发EV-A71相关的手足口病(HFMD)。有些病例有神经系统并发症,并与致命的心肺衰竭密切相关,但并非所有患有中枢神经系统(CNS)的儿童预后都较差。为了确定哪些患者和哪些神经系统并发症更可能发展为心肺衰竭,我们回顾性研究了湖南省1,125名被诊断出患有EV-A71相关手足口病的儿科患者,包括1,017例中枢神经系统受累患者。将这些患者分为心肺功能衰竭组(976人)和无心肺功能衰竭组(149人)。使用逻辑回归分析比较两组之间的临床症状,实验室检查结果和神经系统并发症。最重要的危险因素包括年轻,发烧时间≥3天,昏迷,肢体无力,嗜睡和ANS受累。脑干性脑炎和中枢神经系统受累区域更多的患者更有可能发展为心肺功能衰竭。这些发现可帮助一线临床医生快速准确地确定患者的预后,从而合理地分配有限的医疗资源并尽早实施干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号